QQQ   444.82 (+0.00%)
AAPL   172.00 (-0.76%)
MSFT   421.14 (-0.07%)
META   488.20 (-1.15%)
GOOGL   151.22 (+0.23%)
AMZN   180.54 (+0.39%)
TSLA   176.24 (-2.00%)
NVDA   906.69 (+0.46%)
NIO   4.51 (-3.43%)
AMD   180.55 (+0.53%)
BABA   72.41 (+1.15%)
T   17.63 (+0.46%)
F   13.22 (+1.23%)
MU   117.98 (-0.97%)
CGC   8.63 (-9.63%)
GE   175.33 (-2.66%)
DIS   122.31 (+1.10%)
AMC   3.66 (-15.67%)
PFE   27.82 (+0.14%)
PYPL   67.27 (+1.05%)
XOM   116.08 (+0.97%)
QQQ   444.82 (+0.00%)
AAPL   172.00 (-0.76%)
MSFT   421.14 (-0.07%)
META   488.20 (-1.15%)
GOOGL   151.22 (+0.23%)
AMZN   180.54 (+0.39%)
TSLA   176.24 (-2.00%)
NVDA   906.69 (+0.46%)
NIO   4.51 (-3.43%)
AMD   180.55 (+0.53%)
BABA   72.41 (+1.15%)
T   17.63 (+0.46%)
F   13.22 (+1.23%)
MU   117.98 (-0.97%)
CGC   8.63 (-9.63%)
GE   175.33 (-2.66%)
DIS   122.31 (+1.10%)
AMC   3.66 (-15.67%)
PFE   27.82 (+0.14%)
PYPL   67.27 (+1.05%)
XOM   116.08 (+0.97%)
QQQ   444.82 (+0.00%)
AAPL   172.00 (-0.76%)
MSFT   421.14 (-0.07%)
META   488.20 (-1.15%)
GOOGL   151.22 (+0.23%)
AMZN   180.54 (+0.39%)
TSLA   176.24 (-2.00%)
NVDA   906.69 (+0.46%)
NIO   4.51 (-3.43%)
AMD   180.55 (+0.53%)
BABA   72.41 (+1.15%)
T   17.63 (+0.46%)
F   13.22 (+1.23%)
MU   117.98 (-0.97%)
CGC   8.63 (-9.63%)
GE   175.33 (-2.66%)
DIS   122.31 (+1.10%)
AMC   3.66 (-15.67%)
PFE   27.82 (+0.14%)
PYPL   67.27 (+1.05%)
XOM   116.08 (+0.97%)
QQQ   444.82 (+0.00%)
AAPL   172.00 (-0.76%)
MSFT   421.14 (-0.07%)
META   488.20 (-1.15%)
GOOGL   151.22 (+0.23%)
AMZN   180.54 (+0.39%)
TSLA   176.24 (-2.00%)
NVDA   906.69 (+0.46%)
NIO   4.51 (-3.43%)
AMD   180.55 (+0.53%)
BABA   72.41 (+1.15%)
T   17.63 (+0.46%)
F   13.22 (+1.23%)
MU   117.98 (-0.97%)
CGC   8.63 (-9.63%)
GE   175.33 (-2.66%)
DIS   122.31 (+1.10%)
AMC   3.66 (-15.67%)
PFE   27.82 (+0.14%)
PYPL   67.27 (+1.05%)
XOM   116.08 (+0.97%)
NASDAQ:COO

Cooper Companies (COO) Stock Price, News & Analysis

$101.85
+0.01 (+0.01%)
(As of 03:09 PM ET)
Today's Range
$101.30
$102.17
50-Day Range
$91.92
$102.77
52-Week Range
$75.93
$104.07
Volume
371,680 shs
Average Volume
1.11 million shs
Market Capitalization
$20.24 billion
P/E Ratio
69.64
Dividend Yield
0.01%
Price Target
$108.38

Cooper Companies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
6.6% Upside
$108.38 Price Target
Short Interest
Healthy
1.25% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.17mentions of Cooper Companies in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$5.68 M Sold Last Quarter
Proj. Earnings Growth
11.43%
From $3.50 to $3.90 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.56 out of 5 stars

Medical Sector

287th out of 938 stocks

Ophthalmic Goods Industry

2nd out of 7 stocks

COO stock logo

About Cooper Companies Stock (NASDAQ:COO)

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

COO Stock Price History

COO Stock News Headlines

Investors Alert: The Next Big Thing in Weight Loss
History shows biotech breakthroughs like this can turn small investments into staggering fortunes for those with the foresight to get in early. I've isolated the small company behind it all...
A new IRS program is helping its first users file their income taxes electronically. And it's free
The government's new free electronic filing system for income tax returns is getting its first users this filing season
Investors Alert: The Next Big Thing in Weight Loss
History shows biotech breakthroughs like this can turn small investments into staggering fortunes for those with the foresight to get in early. I've isolated the small company behind it all...
JP Morgan Upgrades Cooper Companies: Here's What You Need To Know
See More Headlines
Receive COO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cooper Companies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
3/28/2024
Next Earnings (Estimated)
6/06/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:COO
CUSIP
21664840
Employees
15,000
Year Founded
1958

Price Target and Rating

Average Stock Price Target
$108.38
High Stock Price Target
$125.00
Low Stock Price Target
$88.75
Potential Upside/Downside
+6.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$294.20 million
Pretax Margin
11.20%

Debt

Sales & Book Value

Annual Sales
$3.67 billion
Cash Flow
$5.13 per share
Book Value
$38.72 per share

Miscellaneous

Free Float
194,781,000
Market Cap
$20.24 billion
Optionable
Optionable
Beta
0.93

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

COO Stock Analysis - Frequently Asked Questions

Should I buy or sell Cooper Companies stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" COO shares.
View COO analyst ratings
or view top-rated stocks.

What is Cooper Companies' stock price target for 2024?

10 equities research analysts have issued 1 year price objectives for Cooper Companies' shares. Their COO share price targets range from $88.75 to $125.00. On average, they predict the company's share price to reach $108.38 in the next twelve months. This suggests a possible upside of 6.6% from the stock's current price.
View analysts price targets for COO
or view top-rated stocks among Wall Street analysts.

How have COO shares performed in 2024?

Cooper Companies' stock was trading at $94.61 at the beginning of 2024. Since then, COO stock has increased by 7.5% and is now trading at $101.67.
View the best growth stocks for 2024 here
.

Are investors shorting Cooper Companies?

Cooper Companies saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 2,480,000 shares, a decrease of 16.5% from the February 29th total of 2,970,000 shares. Based on an average daily trading volume, of 1,080,000 shares, the days-to-cover ratio is currently 2.3 days.
View Cooper Companies' Short Interest
.

When is Cooper Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 6th 2024.
View our COO earnings forecast
.

How were Cooper Companies' earnings last quarter?

The Cooper Companies, Inc. (NASDAQ:COO) issued its earnings results on Thursday, February, 29th. The medical device company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.78 by $0.07. The medical device company earned $931.60 million during the quarter, compared to analysts' expectations of $915.93 million. Cooper Companies had a trailing twelve-month return on equity of 8.79% and a net margin of 7.93%. The company's revenue was up 8.5% on a year-over-year basis. During the same period last year, the firm posted $2.90 EPS.
Read the conference call transcript
.

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies declared a quarterly dividend on Wednesday, July 12th. Shareholders of record on Thursday, July 27th will be given a dividend of $0.0075 per share on Friday, August 11th. This represents a $0.03 annualized dividend and a yield of 0.03%. The ex-dividend date is Wednesday, July 26th.
Read our dividend analysis for COO
.

Is Cooper Companies a good dividend stock?

Cooper Companies (NASDAQ:COO) pays an annual dividend of $0.01 per share and currently has a dividend yield of 0.01%. The dividend payout ratio is 0.68%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, COO will have a dividend payout ratio of 0.26% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for COO.

What ETFs hold Cooper Companies' stock?

ETFs with the largest weight of Cooper Companies (NASDAQ:COO) stock in their portfolio include Invesco ESG NASDAQ Next Gen 100 ETF (QQJG).

When did Cooper Companies' stock split?

Shares of Cooper Companies split before market open on Tuesday, February 20th 2024. The 4-1 split was announced on Tuesday, February 20th 2024. The newly created shares were payable to shareholders after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the split would have 400 shares after the split.

What guidance has Cooper Companies issued on next quarter's earnings?

Cooper Companies updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of 3.500-3.580 for the period, compared to the consensus estimate of 3.460. The company issued revenue guidance of $3.8 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion.

Who are Cooper Companies' major shareholders?

Cooper Companies' stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.54%), Vanguard Group Inc. (2.88%), Veritas Asset Management LLP (4.50%), Capital World Investors (2.83%), Generation Investment Management LLP (2.25%) and Victory Capital Management Inc. (2.01%). Insiders that own company stock include Agostino Ricupati, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Gerard H Warner III, Jody S Lindell and Robert S Weiss.
View institutional ownership trends
.

How do I buy shares of Cooper Companies?

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Cooper Companies have any subsidiaries?
The following companies are subsidiares of Cooper Companies: CVI Contact Lens India Pvt. Ltd., Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., CooperVision (UK) Holdings Ltd., CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, CooperVision Distribution SPRL, CooperVision GmbH, CooperVision Iberia SL, CooperVision International Holding Company LP, CooperVision Italia Srl, CooperVision Japan Inc., CooperVision Ltd., CooperVision Manufacturing Costa Rica SRL, CooperVision Manufacturing Limited, CooperVision Nederland B.V. Belgian Branch, CooperVision Nederland BV, CooperVision Nordic AB, CooperVision Optical Trading (Shanghai) Company Ltd., CooperVision Sarl, CooperVision Singapore Pte Ltd., CooperVision do Brasil Ltda, Coopervision, Coopervision S.A. (Pty) Limited, Invitro Genetics Inc., ORIGIO Inc, Ocular Sciences SAS, Origio A/S, Recombine Inc., Reprogenetics LLC, Research Instruments Ltd., Sauflon CL Ltd, Sauflon CL Manufacturing & Trading Kft, Sauflon Pharmaceuticals Ltd., TCC Holdings S.a.r.l., and The Cooper Companies Global Holdings LP.
Read More
This page (NASDAQ:COO) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners